摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

7-氯-4(3H)-喹唑啉酮 | 31374-18-2

中文名称
7-氯-4(3H)-喹唑啉酮
中文别名
7-氯喹唑啉-4-酮;7-氯-4-羟基喹唑啉;7-氯-4-喹唑啉酮;7-氯喹唑啉-4-醇;7-氯-3H-喹唑啉-4-酮
英文名称
7-chloro-3,4-dihydroquinazolin-4-one
英文别名
7-chloroquinazolin-4(3H)-one;7-chloro-4(3H)-quinazolinone;7-chloro-3H-quinazolin-4-one;7-Chloro-4-hydroxyquinazoline
7-氯-4(3H)-喹唑啉酮化学式
CAS
31374-18-2
化学式
C8H5ClN2O
mdl
MFCD01570890
分子量
180.593
InChiKey
PMLONMIODRHERC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    251-253 °C
  • 沸点:
    331.7±44.0 °C(Predicted)
  • 密度:
    1.50±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    12
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    41.5
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302,H315,H319,H332,H335
  • 储存条件:
    存放于惰性气体中,避免接触空气。

SDS

SDS:8277bd5a924606c41fa89a8bbc99c82c
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 7-Chloro-3h-quinazolin-4-one
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 7-Chloro-3h-quinazolin-4-one
CAS number: 31374-18-2

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H5ClN2O
Molecular weight: 180.6

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    新型青蒿素衍生物及其制法和应用
    摘要:
    本发明涉及新型青蒿素衍生物及其制法和应用。具体地,本发明公开了一类结构如式I所示的青蒿素衍生物或其药学上可接受的盐,或其对映异构体、非对映异构体或外消旋体,其中X、Y、Z、n、k、P如本文中定义。本发明还公开了所述化合物的制法及其应用,所述化合物对治疗肿瘤有优异的效果。
    公开号:
    CN103570738B
  • 作为产物:
    描述:
    2-氨基-4-氯苯甲酰胺盐酸 作用下, 以 原甲酸三甲酯 为溶剂, 以77%的产率得到7-氯-4(3H)-喹唑啉酮
    参考文献:
    名称:
    EP1229025
    摘要:
    公开号:
点击查看最新优质反应信息

文献信息

  • SUBSTITUTED SULFONAMIDE COMPOUNDS
    申请人:OBERBOERSCH Stefan
    公开号:US20080153843A1
    公开(公告)日:2008-06-26
    Substituted sulfonamide derivatives, a process for their preparation, pharmaceutical compositions containing these compounds, and to the use of substituted sulfonamide derivatives in the treatment or inhibition of pain and/or various disorders or disease states.
    磺胺取代物,其制备方法,含有这些化合物的药物组合物,以及磺胺取代物在治疗或抑制疼痛和/或各种疾病或疾病状态中的用途。
  • Synthesis and biological evaluation of a new class of quinazolinoneazoles as potential antimicrobial agents and their interactions with calf thymus DNA and human serum albumin
    作者:Li-Ping Peng、Sangaraiah Nagarajan、Syed Rasheed、Cheng-He Zhou
    DOI:10.1039/c4md00281d
    日期:——
    A series of novel quinazolinone azoles were synthesized and characterized by NMR, IR, MS and HRMS spectra. Bioactive assays showed that some target compounds exhibited significant antimicrobial potency. Especially, nitroimidazole derivative 3a displayed comparable or even superior antibacterial efficacies (MIC = 0.03–0.05 μmol mL−1) in contrast with norfloxacin (MIC = 0.01–0.05 μmol mL−1) and chloromycin
    一系列小说 喹唑啉酮合成了吡咯并通过NMR,IR,MS和HRMS光谱进行了表征。生物活性分析表明,某些目标化合物具有显着的抗菌效力。尤其是,硝基咪唑衍生物3a的抗菌效果与MIC相当,甚至更高(MIC = 0.03-0.05μmolmL -1)。诺氟沙星(MIC = 0.01–0.05μmolmL -1)和氯霉素(MIC = 0.02–0.10μmolmL -1)。通过紫外线可见光谱对化合物3a与小牛胸腺DNA进行的初步互动研究表明,化合物3a可以通过嵌入模式与DNA结合形成化合物3a –DNA复合物,并进一步阻止DNA复制,从而发挥强大的抗菌和抗真菌活性。氢键和范德华力在化合物3a –HSA的缔合中起重要作用。
  • Aniline derivatives
    申请人:Zeneca Limited
    公开号:US05821246A1
    公开(公告)日:1998-10-13
    The invention concerns aniline derivatives of formula I ##STR1## wherein m is 1, 2 or 3, n is 0, 1, 2 or 3, Q is phenyl or naphthyl or a 5- or 6-membered heteroaryl moiety containing 1, 2 or 3 heteroatoms selected from oxygen, nitrogen and sulfur, and X, R.sup.1 and R.sup.2 are defined in the claims; or pharmaceutical compositions containing them, and the methods of using the compounds as tyrosine kinase inhibitors and for the treatment of proliferative diseases such as cancer.
    本发明涉及公式I的苯胺衍生物:##STR1##,其中m为1、2或3,n为0、1、2或3,Q为苯基或萘基或含氧、氮、硫的1、2或3个杂原子的5或6元杂芳基基团,X、R1和R2的定义见权利要求;或包含它们的药物组合物,以及使用该化合物作为酪氨酸激酶抑制剂和治疗诸如癌症的增殖性疾病的方法。
  • Design, Synthesis, and Potency of Pyruvate Dehydrogenase Complex E1 Inhibitors against Cyanobacteria
    作者:Yuan Zhou、Jiangtao Feng、Hongwu He、Leifeng Hou、Wen Jiang、Dan Xie、Lingling Feng、Meng Cai、Hao Peng
    DOI:10.1021/acs.biochem.7b00636
    日期:2017.12.12
    designed and synthesized. A part of 10, 17, and 21 displayed potent inhibition of Escherichia coli pyruvate dehydrogenase complex E1 (E. coli PDHc-E1) (IC50 = 2.12–18.06 μM) and good inhibition of Synechocystis sp. PCC 6803 (EC50 = 0.7–7.1 μM) and Microcystis sp. FACH 905 (EC50 = 3.7–7.6 μM). The algaecidal activity of these compounds positively correlated with their inhibition of E. coli PDHc-E1. In particular
    需要安全有效的除藻剂来控制具有农业和环境意义的藻类。四个系列(6,10,17,和21 29新的4-氨基嘧啶衍生物)的合理设计和合成。的一部分10,17,和21中显示的有效抑制大肠杆菌丙酮酸脱氢酶复合物E1(大肠杆菌PDHC-E1)(IC 50 = 2.12-18.06μM)和抑制良好的集胞藻属。PCC 6803(EC 50 = 0.7–7.1μM)和微囊藻。FACH 905(EC 50= 3.7–7.6μM)。这些化合物的杀藻活性与它们对大肠杆菌PDHc-E1的抑制作用正相关。特别是21l和10b表现出对PCC 6803的强效杀藻活性(分别为EC 50 = 0.7和0.8μM),其值是硫酸铜(EC 50 = 1.8μM)的2倍,并且表现最佳抑制蓝细菌PDHc-E1(IC 50分别为5.10和6.06μM )。17h和21e是大肠杆菌的最佳抑制剂通过分子对接,定点诱变和酶促测定研究了PDHc
  • Photoinduced homolytic decarboxylative acylation/cyclization of unactivated alkenes with α-keto acid under external oxidant and photocatalyst free conditions: access to quinazolinone derivatives
    作者:Bin Sun、Rongcheng Shi、Kesheng Zhang、Xiaoli Tang、Xiayue Shi、Jiayun Xu、Jin Yang、Can Jin
    DOI:10.1039/d1cc02415a
    日期:——
    A novel and green strategy for the synthesis of acylated quinazolinone derivatives via photo-induced decarboxylative cascade radical acylation/cyclization of quinazolinone bearing unactivated alkenes has been developed. The protocol provides a novel route to access acyl radicals from α-keto acids through a self-catalyzed energy transfer process. Most importantly, the reaction proceeded smoothly without
    已经开发了通过光诱导的带有未活化烯烃的喹唑啉酮的脱羧级联自由基酰化/环化反应来合成酰化喹唑啉酮衍生物的新颖和绿色策略。该协议提供了一种通过自催化能量转移过程从α-酮酸中获取酰基的新颖途径。最重要的是,该反应在没有任何外部光催化剂,添加剂或氧化剂的情况下可顺利进行,并且在阳光照射下,在流动条件下很容易按比例放大。
查看更多